Related Experiment Video
Updated: May 27, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
Gene therapy for lung neoplasms
Anil Vachani1, Edmund Moon, Elliot Wakeam
1Division of Pulmonary, Allergy & Critical Care Medicine, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA.
Abstract:
Both advanced-stage lung cancer and malignant pleural mesothelioma are associated with a poor prognosis. Advances in treatment regimens for both diseases have had only a modest effect on their progressive course. Gene therapy for thoracic malignancies represents a novel therapeutic approach and has been evaluated in several clinical trials. Strategies have included induction of apoptosis, tumor suppressor gene replacement, suicide gene expression, cytokine-based therapy, various vaccination approaches, and adoptive transfer of modified immune cells. This review considers the clinical results, limitations, and future directions of gene therapy trials for thoracic malignancies.
Insights
Gene therapy offers a novel approach for thoracic malignancies like lung cancer and mesothelioma, showing potential despite modest effects from current treatments. This review examines gene therapy clinical trial results, limitations, and future directions.
Area of Science:
- Oncology
- Gene Therapy
- Thoracic Malignancies
Background:
- Advanced-stage lung cancer and malignant pleural mesothelioma have poor prognoses.
- Current treatment advancements offer only modest improvements.
Purpose of the Study:
- To review the clinical results, limitations, and future directions of gene therapy trials for thoracic malignancies.
Main Methods:
- Review of clinical trial data for gene therapy in lung cancer and mesothelioma.
- Analysis of various gene therapy strategies including apoptosis induction, gene replacement, suicide gene therapy, cytokine therapy, vaccination, and adoptive cell transfer.
Main Results:
- Gene therapy represents a novel therapeutic avenue for thoracic malignancies.
- Various strategies have been explored in clinical trials.
Conclusions:
- Gene therapy holds promise as a novel approach for thoracic malignancies.
- Further research is needed to overcome limitations and define future directions.
Related Concept Videos
Gene Therapy
Gene Therapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

